Home-grown firm submits its Alzheimer's drug for FDA approval
Sign up now: Get ST's newsletters delivered to your inbox
Yale-NUS College's Assistant Professor Jan Gruber and research fellow Emelyne Teo with a magnified image of the tiny worm called Caenorhabditis elegans. The researchers worked with the worms, which share many similarities with humans at the molecular level, to find a way to fight Alzheimer's disease.
ST PHOTO: KELVIN CHNG
Janice Tai
At least 30 people with Alzheimer's disease in Singapore have tried an experimental drug, developed by a local firm, that is said to slow down progression of the brain disorder.
Currently, drugs on the market treat only the symptoms without affecting the course of the disease.